BCT Reports HLM-354

SEA-HLM-354
Distribution:General
Quality Assurance in Health

Laboratory Services:
A Status Report
Project No: ICP BCT 001

World Health Organization
Regional Office for South-East Asia
New Delhi
March 2003
Page 2
© World Health Organization (2003)
This document is not a formal publication of the World Health

Organization (WHO), and all rights are reserved by the Organization. The
document may, however, be freely reviewed, abstracted, reproduced or
translated, in part or in whole, but not for sale or for use in conjunction
with commercial purposes.
The views expressed in documents by named authors are solely the

responsibility of those authors.
Page 4
PREFACE
WHO has been assiduously promoting quality of health care at all levels.
The health laboratories provide strategic support to both clinical and
public health services in providing quality services. In recent years,
excellent progress has been made in various fields of medicine. These
developments have revolutionized health laboratory services. The latest
molecular tools have greatly enhanced the accuracy of various test
procedures. However, this unparalleled progress in the field of diagnostic
medicine can benefit humanity only if the laboratory services are
accessible to users and the results produced by the laboratories are
reliable, reproducible and rapid enough to be useful.
An optimal utilization of health laboratories is possible only when
laboratory services are planned meticulously and resources invested
judiciously into this area. To achieve this basic prerequisite of the
planning process, WHO has been creating a database of the status of
health laboratories in the Member Countries of the South-East Asia
Region. This information is based on the observations made by large
number of international experts during their recent visits to Member
Countries.
In many countries of our Region, health laboratories have not been
able to contribute optimally because of various reasons, notably: lack of
clearly-defined national policies for laboratory services; shortage of
trained manpower; poor linkages and communication; obsolescence of
health facilities; shortage and inappropriate laboratory equipment; non-
availability and hence non-utilization of standard operating procedure
manuals in laboratory techniques; poor development of internal quality
control methods, and inadequate number of laboratories participating in
external quality assessment schemes.
Page iii
This document is aimed to provide an independent status of health
laboratories in Member Countries of South-East Asia Region to the health
administrators to support them in developing effective plans for
strengthening and utilization of laboratory services.
Dr Sudarshan Kumari
Regional Adviser
Page iv
ACKNOWLEDGEMENT
WHO wishes to acknowledge the services of Prof K.B.Sharma, Centre for

Infectious Diseases Education and Research, Swasthya Vihar, New Delhi,
India for compiling this document on the basis of various reports by
consultants who visited different countries of the South-east Asia Region
during the past three years.
Page iv
ABBREVIATIONS
ABBREVIATIONS AND ACRONYMS
AIIMS All India Institute of Medical Sciences, New Delhi, India
CPHL Central Public Health Laboratories, Colingdale, London,

UK
EQAS External Quality Assessment Scheme
HBsAg Hepatitis B surface antigen
HCV Hepatitis C virus
HIV Human Immunodeficiency Virus
IEQAS International External Quality Assessment Scheme
IPH Institute of Public Health, Dhaka Bangladesh
IQC Internal Quality Control
MDR Multi Drug Resistance
MRI Medical Research Institute, Colombo
NACO National AIDS Control Organization, India
NEQAS National External Quality Assessment Scheme
NHL National Health Laboratories, Yangon
Page v
NICD National Institute of Communicable Diseases, Delhi, India
NICED National Institute of Cholera and Other Enteric Diseases,

Kolkata, India
NIH National Institute of Health, Bangkok, Thailand
NPHL National Public Health Laboratories, Kathmandu, Nepal
QA Quality Assurance
RCPA Royal College of Pathologists of Australia
RIVM Rijksinstituut Voor Volksgezondheid en Mileu
SEAR South-East Asia Region
SOP Standard Operating Procedure
STC Short Term Consultant
STD Sexually Transmitted Diseases
Page vi
CONTENTS
Page
1. INTRODUCTION ...................................................................................1
2. SUBJECT- SPECIFIC LABORATORY NETWORKS .......................................3
2.1 Polio Eradication Programme .................................................3
2.2 AIDS Control Programme .......................................................4
2.3 Tuberculosis ..........................................................................5
3. CURRENT SITUATION OF QUALITY ASSURANCE IN

CLINICAL MICROBIOLOGY IN THE COUNTRIES.......................................5
3.1 Administrative Mechanism .....................................................7
3.2 National Policy for Quality Assurance of Diagnostic

Laboratories 7
3.3 National Policy on Accreditation of Diagnostic Laboratories ...7
3.4 Networking of Diagnostic Laboratories ..................................8
4. COUNTRY-WISE SITUATION OF LABORATORIES IN SEA REGION .............8
5. INFRASTRUCTURE AS RELATED TO DIFFERENT

LEVELS OF LABORATORIES..................................................................24
6. PROGRESS MADE DURING 1996-2001 ................................................17
7. CONSTRAINTS IN ENSURING STANDARDS

IN HEALTH LABORATORIES.................................................................32
Page vii
8. ACTION PLAN FOR STRENGTHENING OF QUALITY ASSURANCE............34
Annexes
1. Status of Quality Assurance Activities in SEAR Countries

26
2. Number of Laboratories in public sector 27
Page viii
1. INTRODUCTION
Quality assurance (QA) in health laboratories incorporates all the
factors that may influence the generation of reliable results. It
comprises two key components. Internal quality control (IQC)
includes appropriate measures taken during day-to-day activities
to control all possible variables that can influence the outcome of
laboratory results. This is a continuous process that operated
concurrently with analysis. External quality assessment scheme
(EQAS) is the other component. This component is necessary to
ensure comparability of results among laboratories. This
component is carried out retrospectively and is conducted by an
independent agency.
WHO has made considerable efforts during the 1990s to

ensure the quality of results produced by laboratories through the
application of quality assurance practices. These efforts have
included advocacy, capacity building and technical support. The
technical discussions at the 49th session of the WHO Regional
Committee for South-East Asia focused on quality assurance in
laboratory practices. All Member Countries recognized that quality
assurance is an important element in the provision of quality
patient care and public health services, and endorsed a resolution
on the need to improve the quality in health laboratories.
There has recently been a phenomenal increase in the number

of health laboratories in the countries of the Region. Awareness
about the need for quality services has also been increasing among
health care providers.
Page 1
Quality Assurance in Health Laboratory Services: A Status Report
The Regional Office has provided technical support and

assisted in the organization of group educational activities in all
countries of the Region. Good laboratory practices have been
emphasized. Guidelines on QA for use in peripheral and
intermediate laboratories have been published, and a six monthly
bulletin on quality assurance is widely disseminated.
Though all Member Countries are making efforts to implement

QA practices in health laboratories, their achievements have not
been uniform.
Only one country – Thailand has a well running EQAS of

microbiology under a national policy of EQAS with well functioning
accreditation system of laboratories. A national policy for QA has
been drafted in Indonesia and Myanmar. In India, there is no
national policy for EQAS as yet, but a programme of networking of
laboratories for surveillance of communicable diseases drawn up
with the help of WHO has been submitted to the Government of
India for implementation. It includes provision of QA as an ongoing
activity involving all laboratories in India.
Though India, Indonesia, Myanmar and Sri Lanka have

developed relatively good mechanisms for the implementation of
QA, provision of EQAS remains largely voluntary. A national policy
for QA of laboratories needs to be drawn up and executed in the
times to come. Steps have been initiated for accrediting
laboratories. Bangladesh, Bhutan, DPR Korea, Maldives and Nepal
are in the process of strengthening their infrastructure and
standardizing their methodologies.
WHO continues to provide technical support to countries to

strengthen IQC and its integration into health laboratories at
various levels of the health care system. The Regional Office is also
Page 2
encouraging the participation of a greater number of laboratories

in EQASs, in order to continue to improve the quality of care.
In addition to quality assurance programmes in public health

laboratories, Bangladesh, India, Indonesia, Myanmar, Sri Lanka and
Thailand are participating in quality assurance programmes in
certain subject-specific programmes viz; poliomyelitis laboratories,
HIV laboratories, blood banks, and tuberculosis laboratories.
2. SUBJECT-
SUBJECT- SPECIFIC LABORATORY NETWORKS
2.1 Polio Eradication Programme
Network of polio laboratories in SEAR

With the help of WHO, laboratories in the Region are carrying out
polio virus isolation from cases of AFP and also from environment.
With impending polio eradication, it is envisaged that these
laboratories will take up other national programmes such as
measles and dengue control programme.
Sixteen laboratories in SEAR countries constitute the network

of polio laboratories. Of these, five serve as reference laboratories.
EQASs are currently in operation. The coded samples prepared for
the global network of laboratories by Rijksinstituut Voor
Volksgezondheid en Mileu (RIVM), Netherlands are distributed.
These laboratories are: IPH in Bangladesh; In India the nine

laboratories are: BJ Medical College, Ahmedabad; Sanjay Gandhi
Post-graduate Institute, Lucknow; Serologists to Government of
India, Kolkatta; National Institute of Virology, Pune; Pasteur
Institute of India, Coonoor; King Institute of Preventive Medicine,
Chennai; National Institute of Communicable Diseases, Delhi;
Page 3
Entro-virus Research Centre, Mumbai and Central Research

Institute, Kasauli. In Indonesia, Provincial Laboratory, Surabaya; in
Myanmar, National Health Laboratory, Yangon; in Sri Lanka,
Medical Research Institute, Colombo and National Institute of
Health in Bangkok. These laboratories take part in IEQAS
conducted by the Netherlands laboratory.
2.2 AIDS Control Programme

Countries of the Region have opened HIV surveillance centres. The
quality assurance programmes of blood banks have been linked
with AIDS control programmes in most of the countries.
Realizing the need for external quality assessment programme

for HIV testing laboratories including blood banks in order to
maintain the validity of HIV tests being carried out at various
levels, the programme of EQAS in HIV testing is being instituted in
all countries. In India, the National Institute of Biologicals (NIB) has
been identified by National AIDS Control Organisation (NACO) as
the apex institute for initiating an EQAS in HIV testing which will
act as the national coordinator of networking. Eleven centers, viz.
NICD, Delhi; AIIMS, New Delhi; Indian Institute of
Immunohaematology, Mumbai; NICED, Calcutta; School of Tropical
Medicine, Calcutta; Madras Medical College, Chennai; National AIDS
Research Institute, Pune; Regional Institute of Medical Sciences,
Imphal; Christian Medical College Vellore; National Institute of
Mental Health and Neuro-Sciences, Bangalore; Dr MGR Medical
College, Chennai have been identified for the implementation of
the external quality assessment programmes in their areas. The
same centres have been asked to conduct EQAS in transfusion
transmitted infectious agents in blood banks for HIV, HBsAg, and
HCV by NACO.
Page 4
Similar programmes have been started in other countries of

the region viz; Institute of Public Health in Dhaka, Bangladesh;
National Public Health Laboratory in Kathmandu, Nepal; Provincial
Laboratory, Surabaya, Indonesia; National Health Laboratory,
Yangon, Myanmar; Medical Research Institute, Colombo, Sri Lanka,
and National Institute of Health, Bangkok, Thailand.
With the help of WHO, selected laboratories in the countries of

the Region are regularly participating in IEQAS in HIV serology
conducted by Australia and CPHL, London.
2.3 Tuber
Tuberculosis
With the upsurge in multidrug resistant tuberculosis in the
countries of the world, especially in association with AIDS, WHO is
conducting an international IEQAS for MDR tuberculosis.
There is a network of five laboratories in India carrying out

surveillance of drug resistant tubercle bacilli in selected districts.
These laboratories are Tuberculosis Research Centre, Chennai;
National Tuberculosis Institute, Bangalore; Lala Ram Swarup TB
Hospital, New Delhi; TB Centre, New Delhi and Maharashtra
Government Institute of Medical Science, Wardha.
In other countries, the participating laboratories are: Centre

Biomedis, Jakarta and Provincial laboratory, Surabaya in Indonesia;
NHL, Yangon in Myanmar; MRI, Colombo in Sri Lanka; NIH Bangkok
in Thailand; Centre for Epidemic Prevention, Pyongyang in DPRK,
and NPHL, Kathmandu in Nepal.
3. CURRENT SITUATION OF QUALITY ASSURANCE IN

IN
CLINICAL MICROBIOLOGY
MICROBIOLOGY IN THE COUNTRIES
Page 5
The South-East Asia Region has 11 countries, of which India and

Indonesia are very large by population and surface area. Medium-
sized countries are Thailand, Myanmar, DPR Korea and Bangladesh;
while Sri Lanka, Maldives, Bhutan, Nepal are small. Provision of
health care services also differs, but is fairly sufficient in most of
the countries. Similarly, although health laboratories exist in all
countries, quality assurance also differs in most countries. The
status of quality assurance in the Member Countries of South-East
Asia Region is given in Annex 1.
WHO consultants visited countries of the Region in the last

eighteen months to assess the current status of quality assurance
in their health laboratory services to identify the major lacunae in
effective implementation of internal quality control and external
quality assessment schemes. The current situation in the countries
presented here is based on these reports.
In spite of continuous endeavours on the part of WHO for

implementation of QA programmes in the countries of the Region
for more than a decade, WHO’s concern is that in most of the
countries, the implementation was not as complete as it should
have been. Even IQC has not been practised regularly in many
laboratories at the intermediate and peripheral levels.
Only one country – Thailand has a well running EQAS of

microbiology under a national policy of EQAS with well functioning
accreditation system of laboratories. National policy for QA has
been drafted in Indonesia and Myanmar. In India, there is no
national policy for EQAS as yet. However, provision of QA as an
ongoing activity involving all laboratories in India is essential.
Accreditation of laboratories on voluntary demand has been
started in India.
Page 6
3.1 Administrative Mechanism

In small countries like Bhutan, Maldives, Nepal and Sri Lanka, the
responsibility for health care including laboratory services lies with
the central ministry of health. Excepting Bhutan, other countries in
this group also have private medical care, which does not come
under the purview of the Government.
Among the medium sized countries, in DPR Korea,

government authority is absolute and there are no private
laboratories in the country. In Myanmar, though government
authority is absolute, some private laboratories have come up in
Yangon and Mandalay. As and when national policy for QA and
accreditation of health laboratories is implemented, it will be
mandatory for private laboratories.
In Bangladesh, most of the laboratories are under the control

of the provincial and central governments. The private laboratories
are absolutely autonomous and as and when national policy for QA
and accreditation of health laboratories is implemented, it should
be mandatory for private laboratories.
3.2 National Policy for Quality Assurance of Diagnostic

Laboratories
The only countries with a national policy for quality assurance are
Indonesia and Thailand; of these, Indonesia has just started, but
Thailand has been practising it for more than 20 years. In India, a
national policy is on the anvil, but it will take some time for it to be
implemented. In other countries, there is no sign of planning such
a policy.
3.3 National Policy on Accreditation of Diagnostic Laboratories
Page 7
India and Thailand have introduced accreditation of laboratories. In

Thailand it has been going on for several years.
In India, it has just been started on a voluntary basis and

largely, private laboratories are coming forward for accreditation.
Once a national policy on networking of laboratories is
implemented, accreditation of laboratories will become mandatory.
In Indonesia, accreditation policy is in the planning stage, but

is likely to be implemented very soon.
None of the other countries viz; Bhutan, Bangladesh, DPR

Korea, Maldives, Myanmar, Nepal and Sri Lanka have as yet started
planning for accreditation of laboratories.
3.4 Networking of Diagnostic Laboratories

Only in Indonesia and Thailand laboratories in the public sector
network. In India, networking of laboratories for surveillance of
communicable diseases is in the planning stage.
4. COUNTRY-
COUNTRY-WISE S
SITUATION
ITUATION OF LABORATORIES
LABORATORIES IN
SEA REGION
The country-wise situation of laboratories in the South-East Asia
Region is given in detail in Annex 2.
4.1 Bangladesh
Health laboratory services structure consists of public sector
laboratories under the various ministries, autonomous medical
university (Bangabandhu Sheikh Mujib Medical University), semi-
government hospital laboratories, nongovernmental organizations
(e.g. BIRDEM) and private laboratories.
Page 8
In the public sector, there is a central laboratory at IPH in

Regional laboratories medical college (13), district level
laboratories (64) and the most peripheral laboratories are at the
Thana Complex (490).
In the Institute of Public Health (IPH) Dhaka, there are

microbiology, polio, epidemiology, food and water testing, drug
testing, IVF section including blood bag unit, reagent production,
antisera production, quality control unit and vaccine laboratories.
In the medical college laboratories, all branches of laboratory

medicine are in existence. In the district level laboratories, mainly
the microscopy of samples, routine clinical pathology and a few
clinical chemistry investigations are done. No culture of samples
for isolation of pathogens is done. At Thana complex, laboratory
minimal microscopy and clinical pathology is being done.
Networking between laboratories for referral of samples, training,
support and supervisory visits is not in place.
An International Centre for Diarrhoeal Diseases Research –

ICDDR-B is functioning in Dhaka since 1970s. It acts as a reference
centre for diarrhoeal pathogens and coordinates with the
Government of Bangladesh in investigations on diarrhoeal
diseases. The centre is very well-equipped and takes part in IEQAS
for enteric pathogens.
There are a large number of laboratories in private sector.

Exact numbers are not known. However, it was estimated to be
around 2 000. In Dhaka alone, there may be more than 400
laboratories.
A reference centre for safe blood transfusion has been

established at Dhaka Medical College with the help of UNDP. The
reference centre will provide referral services for 97 blood banks in
Page 9
the country. Tests for blood-borne infections i.e, HIV, HBsAg, HCV,
malaria and syphilis are being conducted. It will also conduct EQAS
for blood serology and serology of transfusion-borne infections.
IQC is not being followed in the public health laboratories.

NEQAS in clinical microbiology has not yet started. None of the
public sector laboratory is participating in IEQAS in microbiology.
There is neither a national policy for laboratories nor a scheme for
accreditation of laboratories.
The microbiology laboratory of IPH, Dhaka can take up the

responsibility of organizing laboratory for NEQAS in clinical
microbiology. In the initial phase, NEQAS in microscopy to be
introduced followed by culture and antimicrobial susceptibility test
samples. Later, some selected district level laboratories may be
chosen to undertake NEQAS in microscopy for thana-level
laboratories. When the scheme is fully established, private
laboratories are also to be included in the scheme. The NEQAS
organizing laboratory shall participate in International External
Quality Assessment.
A WHO consultant visited Bangladesh in September 2001 and

conducted a orientation course for key trainers in quality
assurance. The participants were senior microbiologists from IPH
and medical colleges of Bangladesh.
A national policy for Quality assurance and accreditation of

laboratories needs to be enunciated and implemented.
4.2 Bhutan
Page 10
Bhutan has a network of health laboratories at the national,

regional and district levels. The administrative authority is the
Ministry of Health of Bhutan. The apex of the structure is
represented by the National Referral Laboratory (NRL) at Thimphu.
Two Regional Referral Laboratories (RRL) are in operation; one at
Monggar for the Eastern Zone and another at Yebilabtsa for the
Central Zone. In addition, there are twenty district laboratories and
eight other hospital laboratories (DHL/OHL).
National guidelines exist for the networking of laboratories

with the main aim of ensuring effective supervision. The national
referral laboratory supervises and supports the work of the
regional referral laboratory which in turn supervises and supports
the work of district and sub-district hospital laboratories. These
district and sub-district hospital laboratories supervise and
support the work of Basic Health Units (BHU).
National Referral Laboratory (NRL) at
Regional Referral Laboratories (RRL)

Monggar for the Eastern Zone Yebilabsta for the Central
District laboratories -28
Peripheral (Basic Health Units) -145
Page 11
There is an EQAS for AFB smear microscopy in operation since

1999. NEQAS for other microscopy parameters and cultures and
antibiotic sensitivity have not been started.
A WHO consultant had conducted a workshop for carrying out

EQAS in clinical microbiology in 1993 and another one in
September 2000 to sensitize technical staff for restarting EQAS in
clinical microbiology.
Previously, the National Referral Laboratory (NRL) at Thimphu

was taking part in IEQAS conducted by RCPA (Australia). It has been
stopped in 1999 due to problems in postage regulations and
financial difficulties.
A national policy for quality assurance and accreditation of

laboratories needs to be enunciated and implemented.
4.3 DPR Korea

DPR Korea has well-structured government health laboratory
services. There are two streams of such laboratories. The stream of
public health laboratories function as laboratories in the Centres
for Prevention of Epidemics. The other stream of laboratories are
those attached to hospitals and in universities.
Type of Laboratories
Anti-
Anti-epidemic University/Hospital
Central 1 6
Provincial 12 36
Country 213 213
Page 12
I. Stream of laboratories in the prevention of epidemics
- Laboratory in the Centre for Prevention of Epidemics –

One central laboratory
- Laboratories in Provincial Centres of Prevention of

Epidemics - 22 District level
- Laboratories in County Centres of Prevention of

Epidemics - 230 Peripheral level
II. Stream of University Hospitals
- University/Hospital at CentralPyongyang University
III. Regional Hospitals - 5
IV. Provincial hospitals at district level - 36
V. County hopsitals at Peripheral level - 213
Quality assurance in the laboratories is non-existent. There

are no private laboratories.
Through its emergency action programme, WHO has been

endeavouring for the past several years in improving the health
laboratories and has provided several consultants to advise on
strengthening of laboratories. Considerable amount of equipment
and reagents were supplied to the stream of laboratories in the
prevention of epidemics.
A WHO consultant visited DPR Korea in March 2000 and had

held a workshop for initiation of QA programmes in the country.
On another visit in July 2001, QA was still not in operation largely
due to paucity of resources. A re-orientation course for key
trainers was carried out to sensitize the nationals.
Page 13
Since all the laboratories are under the administrative control

of the ministry of health, it is expected that further steps for
enunciation and implementation of national policy of quality
assurance and accreditation of laboratories will be taken up as top
priority.
4.4 India
In India, there is no national policy for EQAS as yet, but a
programme of networking of laboratories for surveillance of
communicable diseases has been drawn up with the help of WHO
and has been submitted to Government of India. It includes
provision of QA as an ongoing activity involving all laboratories in
India. Accreditation of laboratories on voluntary demand has been
started, but these are mainly private laboratories. It is hoped that
the national policy for QA, when initiated and implemented, will
encompass accreditation of all the laboratories in the network.
On behalf of the Indian Association of Medical Microbiologists,

the Department of Microbiology of Christian Medical College and
Hospitals, Vellore, Tamil Nadu has been organizing an external
quality assessment scheme (EQAS) in microbiology for laboratories
in India. The participation is voluntary. A total of 52 laboratories
are participating in this EQAS, some of which belong to the private
sector.
On behalf of the Indian Association of Pathologists and

Microbiologists, the Department of Pathology, Banaras Hindu
University, Varanasi started EQAS in clinical pathology and
biochemistry in 1990 and EQAS for microscopy in clinical
microbiology was started in 1998.
Page 14
4.5 Indonesia
The Directorate for Health Laboratories (Direktorat Laboratorium
Kesehetan – Dit Lab Kes) is the supreme controlling authority in
Indonesia. It controls the public health laboratories in the 26
provinces of Indonesia and is responsible for their functioning and
carrying out activities for public health in the respective provinces.
In coordination with the appropriate directorates in the Ministry of
Health, it also controls the pathology laboratories in the Ministry of
Health, Government hospitals, and peripheral health laboratories.
With this mandate, it has been carrying out external quality
assessment in various disciplines of laboratory medicine.
WHO has been closely associated with this activity since its
inception. In 1989 a workshop was held in Yogyakarta for the
initiation of EQAS in clinical microbiology. Under the WHO/UNDP
project, another workshop was held in 1992 in EQAS for laboratory
medicine, clinical chemistry and clinical microbiology.
The Yogyakarta BLK has been participating in IEQAS in clinical

microbiology conducted by Belgium for the past 12 years. Since
1989 EQAS is also being carried out there.
The microscopy subscheme for acid-fast bacilli was started in

1994, along with microscopy for malaria and faecal parasites. The
EQAS for clinical microbiology now covers 80 laboratories, while 1
750 laboratories for AFB, 1 500 for malaria and 1 500 for faecal
ova are covered for microscopy.
NEQAS for immunology and serology is being conducted by

BLK Surabaya since 1991 in which 160 laboratories are
participating. It covers four parameters viz., VDRL, Widal, HBsAg,
anti HIV. Networking has been started and in 2000 the
Page 15
responsibility of EQAS in AFB microscopy has been given to

provincial laboratories.
Considering the EQAS in clinical microbiology, the

performance of most laboratories is variable for isolation and
identification of cultures, but is consistently good for antibiotic
sensitivity testing.
WHO consultant conducted an orientation course for key

trainers for expansion of QA network in Indonesia in November
2000. He also submitted an action plan for expansion of the
quality assurance network. Directorate of Health Laboratories is the
national authority that deals with health laboratories. Central
laboratory for EQAS is located in BLK Yogyakarta. Indonesia has 26
provincial laboratories (Class A 5 and Class B 21), and 329 District
Laboratories (Class B,C,D Hospitals).
4.6 Maldives
There are twenty three (23) health laboratories in the Maldives. Of
these, fourteen are situated in the island of Male’ and nine outside.
Of the fourteen laboratories in Male’, there are three large
laboratories, namely, the Indira Gandhi Memorial Hospital (IGMH)
laboratory, which is the main laboratory in the country concerned
with patient care, the Public Health Laboratory (PHL), dealing with
food, water and sanitation aspects and the “ADK” laboratory, a
large private laboratory. Additionally, there are three medium-
sized and eight small laboratories.
The hospitals and laboratories of the public sector are

administered by the Ministry of Health. The Indira Gandhi Memorial
Hospital, the thalassemia centre and the regional hospitals are
directly administered by the Ministry of Health, while the public
Page 16
health laboratory is administered by the Public Health Department.

The private sector laboratories are independent organizations.
Outside Male’, the laboratory service consists of five regional

laboratories and four smaller laboratories (atoll hospital
laboratories). All laboratories apart from IGMH and the public
health laboratory are manned by medical laboratory technicians
(MLT).
Apart from the staff of IGMH and PHL, the laboratory staff in
the other establishments have very little knowledge of the concept
of quality assurance. The ADK hospital laboratory, the private
medical laboratory is well equipped and the staff is aware of the
concept of quality assurance.
There is no clear national laboratory policy, or quality

assurance policy in place at present and no system of laboratory
accreditation exists. There is also no state control over eight
laboratories in the private sector. At district level there are 11
laboratories and in addition, regional hospitals have their own
laboratory support services.
Regional hospitals
(1) Addu regional hospital laboratory
(2) Kulhudhuffushi regional hospital laboratory
(3) Ugoogaaru regional hospital laboratory
(4) Mulee regional hospital laboratory
(5) Thnadhoo regional hospital laboratory
(6) Eydhafulah atoll hospital laboratory
(7) Fuahmulah atoll hospital laboratory
(8) Naifaru atoll hospital laboratory
(9) Laamu atoll hospital laboratory
Page 17
4.7 Myanmar
Administratively, the country is divided into 17 states and divisions
with 52 districts, 324 townships (rural and urban). The population
of the country is 50 million with more than 75 % population
residing in the rural areas.
The laboratory services provide the essential backbone

support for the prevention, control and treatment of diseases and
other related health care programmes being carried out in
Myanmar in the context of the National Health Plan.
In general, laboratory facilities in Myanmar are graded into

three types A, B and C with the National Health Laboratory as the
Central Reference Laboratory. Type A laboratories serve the states
and division level, Type B at the district level and type C at the
township level.
There are 38 type A laboratories attached to teaching

hospitals, general hospitals, and specialist hospitals, 33 type B
laboratories attached to district hospitals and 281 township
hospitals that are served by type C laboratories.
Type A laboratories are generally headed by consultant

pathologists who look after microbiology, clinical chemistry,
haematology, and blood banking. They serve hospitals with a bed
strength of 200 and above.
Type B laboratories are headed by medical technologists. They

carry out services in clinical chemistry, haematology, microbiology
and blood banking. The hospitals served by type B laboratories
have a bed strength of 100-150.
Type C laboratories carry out the tests classified under

essential clinical chemistry, essential haematology, public health
Page 18
microbiology and blood banking. The number of hospital beds

served by these laboratories are generally 16 to 50.
In general, type A laboratories carry out 200-500 tests per

day, type B laboratories, 50 to 200 test and type C laboratories 10-
50 tests per day.
Level Type of Labs
Central level NHL Yangon
State level 38 (Grade A)
District level labs 33
Peripheral – Township 281
International training on quality assurance has been carried

out from time to time in Myanmar. A WHO/DANIDA National
Training Course on Quality Control in Clinical Microbiology was
held from 6-17 January 1986 with 24 participants, microbiologists,
pathologists and medical technologists from all over Myanmar.
A national workshop on introduction of Quality Standards and

Appropriate Technology for Primary Health Care Laboratory
Services, was held from 15-17 November 1990. WHO STC, 20
participants – laboratory personnel from peripheral, district and
central labs and authorities from community health and
communicable diseases control work participated.
A three day national workshop on the Introduction and

Establishment of External Quality Assurance Network was
conducted in Yangon from 13-15, November 1992. A workshop on
Development of Laboratory Efficiency and Quality Assurance
Page 19
Scheme was held from 11-13 May, 1998, and a training course for
Key Trainers in Quality Assurance from 11-13 September 2000.
NEQAS in microbiology is conducted by NHL. It started in 1986

with 15 type A laboratories participating. In 1993, it was
reorganized to include parasitology and mycology. Since 1996,
there are 22 participating laboratories.
4.8 Nepal
Nepal has a network of 185 health laboratories in the Government
sector that are scattered in various geographical regions of the
country.
At the central level - the National Public Health Laboratory

(NPHL) is located at the Department of Health Services premises,
Teku, Kathmandu. There are six central level hospital (250-350
beds) laboratories in Kathmandu, the Bir Hospital, the Kanti
Children Hospital in Patan, the maternity hospital, the National
Tuberculosis Centre in Thimi and the Ayurvedic Hospital. There is
one regional hospital (200 beds) laboratory in the Western Region
in Pokhara and one sub-regional hospital laboratory in the central
region in Birgunj. In addition, there are nine zonal, 64 district, 132
PHC and 24 health post laboratories.
Recently Guidelines on SOP in clinical chemistry,haematology,

microbiology and blood banking have been printed. A quality
assurance programme is being conducted by the National Public
Health Laboratory (NPHL) with the help of the International Nepal
Fellowship (INF). An external quality assessment scheme for
various parameters is also in operation in which 54 laboratories
participate.
Page 20
Type of Laboratory Number
Central Laboratory – National Public Health 1

Laboratory (NPHL)
Central level hospital laboratories 6
Regional laboratories 2
District level 73
(9 zonal, 64
district)
Peripheral level 156
Private laboratories Not available
4.9 Sri Lanka

There are three levels of curative care institutions administered by
the Ministry of Health:
(1) The central dispensaries, maternity homes, rural

hospitals, peripheral units and district hospitals are
primary health care institutions.
(2) The base hospitals (n=33) and provincial hospitals (n=05)
are secondary care institutions.
(3) The teaching (n=15) and special hospitals (5) are tertiary
care institutions.
Type of Laboratory Number
Central lab: MRI Colombo 1
Central Level: Teaching and special 20

hospitals
Page 21
District laboratories 38
Peripheral laboratories 523
A WHO STC visited in 1997 and conducted a workshop on

quality assurance in microbiology.
Medical Research Institute, Colombo, Sri Lanka (MRI) initiated

a national external quality assessment scheme (NEQAS) in 1997 in
bacteriology for laboratories in government institutions and
universities. Fourteen laboratories agreed to participate during
1997 and 18 in 1998. Three cycles of NEQAS were completed in
1997. In each cycle, two bacterial isolates were sent for
identification and determination of antimicrobial susceptibility
testing (AST). Now 30 government hospital laboratories participate
in NEQAS.
The Central Laboratory STD/HIV runs NEQAS in VDRL serology

since 1998 in which 19 laboratories participate. It has started a
reverse proficiency testing in STD microscopy since June 2000 in
which 12 STD laboratories send all their reported positive smears
and 5% of the negatives to the Central Laboratory for cross
checking.
4.10 Thailand
The Bureau of Laboratory Quality Standards - BLQS

As one of the bodies of the Department of Medical Sciences
(DMSc), the Bureau of Laboratory Quality Standards (BLQS) is
responsible for laboratory quality assurance in a range of medical
science areas aiming to control the quality of test results, to
promote the implementation of reference laboratories and to
Page 22
develop the operation quality of consumer protection and clinical

laboratories.
Accreditation of laboratories according to ISO/IEC 17025

International Standards
This programme is offered with different purposes. One is to
entitle the accredited laboratories to operate laboratory services
for health product registration at Thai-FDA, they can also
undertake services to FDA in product assessment for consumer
protection surveillance. The BLQS also accredits clinical
laboratories of the private sector and those who are responsible for
health check of people working abroad. Examples are diagnostic
laboratories and food, drug, cosmetics, condom and clinical
laboratories.
EQAS
This service is provided to laboratories of both public and private
sectors throughout the country, especially those of clinical
laboratories covering the areas of clinical chemistry, clinical
microscopy, clinical microbiology, haematology, clinical
immunology, and blood banking. Altogether, there are now 600
health stations joining this programme, which is 20 years old.
There are three levels of hospitals:
(1) 12 regional – Many provinces come together

(2) 73 provincial – for each province
Page 23
(3) Community – for each community

(4) Health centre - > 15 000. Medical doctor may not be
there
(5) 141 private laboratories: also take part in NEQAS.
The regional hospital serves as a referral centre, and provides

training and advice for staff in smaller hospitals. All
laboratories/hospitals have to be registered.
Since participation in EQAS is free, there seems to be no

constraint to participation. The registration fee for laboratories has
also been kept minimal to encourage all laboratories to participate,
since participation in EQAS is voluntary.
There exists a fairly advanced quality assurance system in
practice in medical laboratories in Thailand – much more than is in
existence in the other countries.
5. INFRASTRUCTURE AS RELATED
RELATED TO DIFFERENT
LEVELS OF LABORATORIES
LABORATORIES
The details of infrastructure available at different levels of
laboratories are provided in Table 1. Broadly, the human resource,
equipment, quality control measures, documentation, technical
expertise and infrastructure available in the central laboratories
and medical colleges laboratories conform to international
requirements, rules and regulations. Infrastructure is weak at the
peripheral laboratories. Adequate human resource is available only
in some peripheral laboratories and their continuous training and
upgradation of skills are rarely undertaken. These laboratories
document most of their activities and results, but are deficient in
internal quality control, availability and maintenance of equipment
as well as quality reagents, kits, antisera and other chemicals.
Page 24
6. PROGRESS MADE DURING 1996-

1996-2001
WHO has been endeavouring to promote the practice of
quality assurance in the countries of the Region since the 1980s.
Consultations provided and workshops conducted from time to
time did sensitize some countries in the practice of quality
assurance with emphasis on IQC and the need for starting EQAS
programmes.
Table 1
Status of IQC parameters-
parameters-
STATUS OF QUALITY ASSURANCE ACTIVITIES IN SEAR COUNTRIES
Page 25
Parameter for quality Bhutan Bangladesh DPR Korea Indonesia India

assurance of diagnostic labs
1 Status of IQC parameters
Central level
Adequacy of staff
Professional Yes Yes Yes Yes Yes
Supportive Yes Yes Yes Yes Yes
Training of staff Yes Yes Yes Yes Yes
Availability and use of SOP Yes/WHO Yes/WHO Yes /WHO Yes/Own Yes/WHO
Equipment maintenance Yes Yes Yes Yes Yes
Documentation Good Good Good Good Good
Internal quality assessment Yes Yes No Yes Yes
Internal audits Rarely Rarely No Yes Rarely
Medical College
labs/Regional/Provincial
Adequacy of staff
Availability and use of SOP Yes/WHO Yes/WHO Yes/WHO Yes /Own Yes /WHO
Equipment maintenance Yes Yes Yes Yes Yes
Internal quality assessment Yes Yes No Yes Yes
Internal audits Rarely Rarely No Yes Rarely
District level
Adequacy of staff
Availability and use of SOP No Yes/WHO No Yes/Own Yes /WHO
Equipment maintenance Yes Yes Rarely Yes Yes
Internal quality assessment No No No Yes Yes
Internal audits Rarely Rarely No Rarely Rarely
Peripheral level
Page 26
Adequacy of staff
Professional No No No No Yes
Training of staff Rare Rare Rarely Yes Yes
Availability and use of SOP No No No Yes /Own Yes /WHO
Equipment maintenance Rarely Rarely Rarely Yes Yes
Internal Quality assessment No Rarely No No Yes
Internal audits Rarely Rarely No Rarely Rarely
Page 27
QA was started on a small scale in countries like Myanmar,

Indonesia, Nepal and Sri Lanka in early 1990s. Only Thailand has
had a fairly advanced quality assurance system in practice for the
last twenty years.
Since 1996, some countries have started EQAS in
microbiology. In India, the largest country in the Region, it started
as a voluntary participation programme in 1997 and the
participation is increasing slowly.
At the behest of Indian Association of Medical Microbiologists,
the Christian Medical College, Vellore started EQAS in clinical
microbiology. To begin with, 22 laboratories signed up but by
2001, the number has risen to 52. It may be mentioned that
participation is mainly voluntary and a few private laboratories are
also participating.
Another EQAS provider, the Department of Pathology, BHU,
Varanasi, started EQAS for microscopy in clinical microbiology in
1998. This scheme is also purely voluntary.
A programme of networking of laboratories for surveillance of
communicable diseases drawn up with the help of WHO has been
submitted to the Government of India. It includes provision of QA
as an ongoing activity involving all laboratories in India.
Accreditation of clinical laboratories has been started by the
Department of Biotechnology, Government of India in 1999. This is
largely voluntary and mostly private laboratories are coming
forward for accreditation. In the last two years, 22 private
laboratories have been accredited. It is hoped that the national
policy for QA, when initiated and implemented, will encompass
accreditation of all the laboratories in the network.
Page 28
In Indonesia, though the EQAS in clinical microbiology is

continuing since 1989, it was being provided by one provincial
laboratory – BLK Yogyakarta. It was decided to increase the ambit
of the QA programme by networking, so that all laboratories in the
country could be involved in the practice of QA on an ongoing
basis. A consultant visited Indonesia in 1999 and prepared a plan
for expansion of QA in clinical microbiology as a network, which is
now being implemented.
In Myanmar, NEQAS in microbiology is conducted by NHL
since 1986 and since 1996, the number of participating
laboratories has increased.
In Nepal, Quality Assurance Programme has been started since

1996 and is conducted by the National Public Health Laboratory
(NPHL) as shown in Table 2
Page 29
Page 30

Table 2
Organization of EQAS
Parameter for quality

Bhutan Bangladesh DPR Korea Indonesia India Maldives Myanmar Nepal Sri Lanka Thailand
assurance of diagnostic labs
National policy and guidelines No No Yes Yes In Planning No In No No Yes
1 for quality assurance of CMC planning-
diagnostic labs
Organizing Unit NEQAS NRL- TGH -No No BLK CMC No NHL NPHL MRI BLQS/DMS
Analytes AFB Yogyakarta Vellore Yangon Clinical Clinical c
2
Microscopy Voluntary Clinical microbiol microbiol
microbiol
Number of participating units ?- No No + 52 No 15 in 1980 54- 14 in 1997 N.A.
3 22 in 1996 30 in 2001
Feedback mechanism -? No No By post By post No Post- Post- Post Post
4
Networking of EQAS No No- No In planning No No- No- -No No No

5
Participation in IEQAS Not since No No- Yes Yes No No No Yes since Yes
6 1999 Belgium Belgium 1988 Australia
Accreditation - - - - -
National policy No No No Yes Yes No No No No Yes
Process - - - DIT LabKes NABL - - - - BLQS

Page 31
In Sri Lanka, MRI initiated a national external quality

assessment scheme (NEQAS) in 1997 in bacteriology for
laboratories in government institutions and universities. Fourteen
laboratories agreed to participate during 1997 and 18 in 1998.
Now 30 government hospital laboratories participate.
For specific programmes
(a) STD/HIV Central Laboratory runs NEQAS in VDRL serology

since 1998 in which 19 laboratories participate and, (b) Central
Laboratory STD/HIV has started a reverse proficiency testing in STD
microscopy since June 2000 in which 12 STD laboratories send all
their reported positive smears and 5% of the negatives to the
central laboratory for cross checking.
It will be seen that Bangladesh, Bhutan, DPR Korea and

Maldives need to start EQAS in clinical microbiology. Other
countries such as India, Myanmar, Nepal and Sri Lanka should
adopt networking of all their laboratories for EQAS purposes to
involve all the laboratories in their countries.
7. CONSTRAINTS IN ENSUR
ENSURING
ING STANDARDS IN
HEALTH LABORATORIES
Several constraints were identified in ensuring quality standards in
health laboratories. These include:
(1) Lack of national health policy on laboratory services;
(2) Absence of mandatory national quality assurance

programme;
(3) Inadequate funding;
Page 32
(4) Shortage of qualified laboratory staff in most countries of

the Region;
(5) Deficient education and training of staff in QA in all its

aspects;
(6) Absence of continuing medical education (CME)

programmes for QA in most countries;
(7) Irregular supply of equipment and materials (media,

chemicals, reagents, antisera and disposables);
(8) No set norms in health laboratory establishments;
(9) Low priority to laboratory services in hospital set-up;
(10) Limited laboratory space for microbiology and inadequate

numbers of technicians in most laboratories;
(11) Non-availability of authenticated standard operating

procedure manuals in clinical microbiology and biosafety;
(12) NEQAS in clinical microbiology not started in many

countries. IQC not being followed;
(13) Failure of laboratories to keep pace with clinical

specialization;
(14) Mutual distrust between clinician and pathologist;
(15) Absence of regular discussions and meetings between

laboratory officials and clinician/public health physicians;
(16) Lack of modern equipment for improving conduct of

quality assurance;
(17) Unsatisfactory maintenance of equipment;
(18) Erratic supply of electricity and water in most countries;
Page 33
(19) Non-availability of quality reagents and kits, and
(20) Absence of networking between laboratories for referral

of samples, training, support and supervisory visits.
8. ACTION PLAN FOR STRENGTHENING

STRENGTHENING OF
QUALITY ASSURANCE
Strengthening of quality assurance in health laboratories in SEAR
countries will require improvements in internal quality control
measures along with a mechanism for assessment of quality. The
former is a continuous process whereas the latter, being a tool to
assess the former requires regular, but periodic, participation.
8.1 Internal quality controls

Every laboratory must strive to ensure implementation of internal
quality control measures. Achieving quality should be the objective
and responsibility of all the staff members of the laboratory,
irrespective of their status in the hierarchy. Top management must
play the role of catalyst, supervisor and motivator in ensuring
quality of the results of the laboratory and strive for continuous
quality improvement. A review of the current status should be
made, deficiencies identified and appropriate steps initiated
through an action plan to put a reliable and sustainable quality
system in place in the laboratory.
The internal quality control measures encompass all aspects

of health laboratories and can be grouped under various important
key elements, each being composed of many sub elements:
Management
! Policy and commitment for quality
Page 34
! Planning
! Allocation of appropriate resources
! Provision of suitable infrastructure, material, manpower
! Networking between laboratories
! Biosafety
! Errors management
! Participation in EQAS, accreditation
Standards
! National
! International
Training
! Induction training
! In-service training to upgrade the skills in specific areas
Documentation
! Quality Manual
! SOP
! Worksheets
! Records
Monitoring, evaluation
! Use of statistical process tools
! Internal assessment
! Internal audit
8.2 Assessment of quality
Page 35
The retrospective and periodic assessment of quality can be

undertaken by an independent external agency or internally by the
designated staff on behalf of the laboratory management. Quality
can be thus assessed by an on-site inspection by trained
professionals (viz. auditors) or by processing of the material sent
by a designated institution. Accordingly, assessment of quality can
be man-driven (audit: internal or external) or material driven
(quality assessment: internal or external).
The main objective of external quality assessment (EQA) which

is done in planned and a schematic way is to establish inter-
laboratory comparability. This will influence the reliability of future
testing. In contrast, the main objective of internal quality control is
to ensure day-to-day consistency. Hence, both internal quality
control (IQC) and quality assessment are complementary in
ensuring the reliability of procedures, their results and finally the
quality of the product.
External Quality Assessment Scheme

The assessment of quality in a schematic way through an
external agency using material of known but undisclosed results is
called external quality assessment scheme (EQAS). This is
considered a powerful tool that challenges the internal quality
control measures being adopted by the laboratory. EQAS is a tool
by which the entire testing process, including the quality of results
generated by a particular laboratory is assessed.
External quality assessment scheme compares the

performance of different testing sites and challenges other
components of the quality assurance system (internal quality
control). This assessment is achieved through processing of
Page 36
specimens of undisclosed but known contents. It measures the

accuracy of the results.
Objectives of external quality assessment scheme
EQAS are organized to achieve the following objectives:
(1) Monitoring laboratory performance and evaluation of

quality control measures;
(2) Establishing inter-laboratory comparability;
(3) Influencing reliability of future testing;
(4) Ensuring credibility of laboratory;
(5) Stimulating performance improvements;
(6) Promoting high standards of good laboratory practices;
(7) Encouraging use of standard reagents/methodology and
trained personnel;
(8) Identifying common errors;
(9) Providing mechanisms to remedy identified deficiencies;
(10) Facilitating information exchange;
(11) Supporting accreditation, and
(12) Educating through exercises, reports and meetings.
Process of EQAS
EQAS requires a well-equipped, experienced laboratory at the

intermediate or central level to act as the organizing laboratory
and a fairly reasonable number of laboratories as the participating
laboratories. The process of EQAS with important functions of
organizing and participating laboratories has been shown in Fig
Organizing laboratory Participating laboratory
Page 37
Preparation of quality Examination of specimens

assurance specimens
Analysis of results
Reporting results
Preparation of report
Evaluation
The external assessment of laboratories is beneficial in the

following ways:
(1) Helps laboratories in comparing their results with other

laboratories;
(2) Acts as an educational stimulus to laboratory staff;
(3) Participation provides credibility to the laboratory;
(4) Helps the health administrators and regulatory agencies
to have an insight into the status of quality across the
country, identifying the problems and devising
methodology to overcome these.
The above-mentioned features should be incorporated by
Member Countries in their plan of action for improving the quality
of laboratories in SEAR countries.
Page 38
Ann
Annex 1
STATUS OF QUALITY AS
ASSURANCE
SURANCE ACTIVITIES IIN
N SEAR COUNTRIES
Parameter for
quality assurance DPR
BHU BAN INO IND MAV MMR NEP SRL THA
of diagnostic K
laboratories
1. National policy
and guidelines
for quality
- - - - - - - - - +
assurance of
diagnostic
laboratories
2. National policy
on accreditation
- - - - + - - - - +
of diagnostic
laboratories
3. National
regulatory
authority
- - + + + - - - - +
assuring quality
of diagnostic
laboratories
4. Networking of
diagnostic - - - + - - - - - +
laboratories
5. National
Regulatory
- - - - - - - - - +
Laboratory for
diagnostic kits
6. Availability of - - - +@ +@ - +@ - - +
SOPs for IQC &
Page 39
EQAS
7. Networking of
laboratories for - - - - - - - - - +
quality assurance
8. Organization of
- - - + +* - + - +* +
NEQAS
* Mainly on voluntary basis by NEQAS providers and participating labs.

@ Available only in central
central laboratories
Page 40
Annex 2
Number of Laboratories in public sector
Parameter for
quality
assurance of BHU BAN DPRK IND
IND INO
INO MAV MMR NEP SRL THA
diagnostic
laboratories
1. Number of
laboratories in
public sector
Central level 1 1 1 1 1 2 1 1 1 1
Medical college
laboratories/ 180+
13 2 26 9 38 6+2 20 12
Regional/ 31
Provincial
District level 12+

64 28 535 329 11 33 73 38 73
36
Peripheral level CHC

213 2500
490 145 + PHC
213 1900
0
2. Number of
laboratories in 2000 Nil Nil N.A N.A N.A N.A N.A
private sector
Page 41
Laboratories in
metropolitan 400 8 4
cities
Laboratories in
N.A N.A
Districts
Laboratories in
N.A N.A
villages
NA – Not Available
Page 42
Page 43

BCT Reports HLM-354

Uploaded by

Copyright:

Available Formats

BCT Reports HLM-354

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

BCT Reports HLM-354

Uploaded by

Copyright:

Available Formats

SEA-HLM-354

Quality Assurance in Health

Project No: ICP BCT 001

This document is not a formal publication of the World Health

The views expressed in documents by named authors are solely the

WHO wishes to acknowledge the services of Prof K.B.Sharma, Centre for

AIIMS All India Institute of Medical Sciences, New Delhi, India

CPHL Central Public Health Laboratories, Colingdale, London,

EQAS External Quality Assessment Scheme

HBsAg Hepatitis B surface antigen

HCV Hepatitis C virus

HIV Human Immunodeficiency Virus

IEQAS International External Quality Assessment Scheme

IPH Institute of Public Health, Dhaka Bangladesh

IQC Internal Quality Control

MDR Multi Drug Resistance

MRI Medical Research Institute, Colombo

NACO National AIDS Control Organization, India

NEQAS National External Quality Assessment Scheme

NHL National Health Laboratories, Yangon

NICED National Institute of Cholera and Other Enteric Diseases,

NIH National Institute of Health, Bangkok, Thailand

NPHL National Public Health Laboratories, Kathmandu, Nepal

RCPA Royal College of Pathologists of Australia

RIVM Rijksinstituut Voor Volksgezondheid en Mileu

SEAR South-East Asia Region

SOP Standard Operating Procedure

STC Short Term Consultant

STD Sexually Transmitted Diseases

2. SUBJECT- SPECIFIC LABORATORY NETWORKS .......................................3

2.1 Polio Eradication Programme .................................................3

2.2 AIDS Control Programme .......................................................4

2.3 Tuberculosis ..........................................................................5

3. CURRENT SITUATION OF QUALITY ASSURANCE IN

3.1 Administrative Mechanism .....................................................7

3.2 National Policy for Quality Assurance of Diagnostic

3.3 National Policy on Accreditation of Diagnostic Laboratories ...7

3.4 Networking of Diagnostic Laboratories ..................................8

4. COUNTRY-WISE SITUATION OF LABORATORIES IN SEA REGION .............8

5. INFRASTRUCTURE AS RELATED TO DIFFERENT

6. PROGRESS MADE DURING 1996-2001 ................................................17

7. CONSTRAINTS IN ENSURING STANDARDS

1. Status of Quality Assurance Activities in SEAR Countries

WHO has made considerable efforts during the 1990s to

There has recently been a phenomenal increase in the number

The Regional Office has provided technical support and

Though all Member Countries are making efforts to implement

Only one country – Thailand has a well running EQAS of

Though India, Indonesia, Myanmar and Sri Lanka have

WHO continues to provide technical support to countries to

encouraging the participation of a greater number of laboratories

In addition to quality assurance programmes in public health

2.1 Polio Eradication Programme

Network of polio laboratories in SEAR

Sixteen laboratories in SEAR countries constitute the network

These laboratories are: IPH in Bangladesh; In India the nine

Entro-virus Research Centre, Mumbai and Central Research

2.2 AIDS Control Programme

Realizing the need for external quality assessment programme